BioVision, Inc. Press releases
Aug 15, 2016
BioVision introduces Phospho-p38 MAPK (Thr¹⁸⁰+Tyr¹⁸²) Translocation Assay Kit (Cell-Based) for research in the areas of inflammation, stress,autophagy, cell differentiation and many others.
Aug 04, 2016
BioVision proudly announces the launch of highly pure and effective recombinant Cas9 proteins, Antibodies, Homology Directed Repair (HDR) Blockers and Enhancers for Genome Editing Studies using CRISPR/Cas9 Technology.
Jul 07, 2016
Exosomes are small endosome derived lipid nanoparticles (50-120 nm in diameter) actively secreted by exocytosis in most living cells.
May 19, 2016
BioVision proudly announces the launch of the Molecular Bology Grade Fabulously Active FabActTM Proteinase K (recombinant), which is the most powerful proteinase among all proteinases characterized so far.
May 10, 2016
BioVision proudly announces the launch of GeneGlideTM Transfection Reagents that are ideal for delivering nucleic acids including DNA, siRNA, miRNA to mammalian cells.
May 06, 2016
BioVision, Inc., proudly announces the launch of a Multidrug Resistance Assay Kit. The assay can be HTP adaptable and does not require special equipment.
Apr 13, 2016
Trial size antibodies are convenient and economical solution for researchers to explore several targets for screening. BioVision is releasing hundreds of best performing Trail size antibodies to meet all your early stage research needs.
Apr 06, 2016
Enzyme-linked Immunosorbent Assay (ELISA) is a powerful analytics tool to quantify proteins and small molecules in serum, plasma, tissue homogenates and other biological fluids.
Jan 22, 2016
Biovision proudly announces the launch of a wide selection of products dedicated to exosome research. This includes high quality reagents and kits that are quick and easy to use.
Jan 07, 2016
BioVision, Inc. proudly announces the launch of the first fluorometric PPARγ Ligand Screening/Characterization Assay Kit. The assay can be HTP adaptable and does not require special equipment.